Navigation Links
University of Delaware to lead DoD orthopaedic rehabilitation consortium
Date:10/19/2011

The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) Peer Reviewed Orthopaedic Research Program (PRORP) has awarded a $19.7 million grant to the University of Delaware to create and manage a consortium that will improve the quality of life for warfighters who suffer significant limb injuries in combat.

The Bridging Advanced Developments for Exceptional Rehabilitation (BADER) Consortium will conduct clinical trial research at several hospitals, both military and civilian, across the country.

"This consortium will greatly advance post-injury treatment, and will develop new standards of care for not only these service men and women, but also for Americans with limb damage from accidents," said CDMRP Director COL Jeffrey Leggit, M.D. "Working together, the scientists, clinicians, and patients of these premier organizations will be able to more effectively analyze the benefits of potential treatments, and bring these practices forward rapidly."

COL Leggit added that the long-term goal of the consortium is to create an infrastructure of relationships among the participating organizations, allowing the consortium to operate as an independent entity for clinical trials.

Dr. Steven Stanhope, a professor in Delaware's Department of Kinesiology and Applied Physiology, will serve as principal investigator and consortium director. Dr. Stanhope expressed his vision and goals for the consortium.

"An important characteristic of the BADER Consortium is the exceedingly high level of collaboration we ultimately seek to establish between military treatment facilities, the Veterans Administration, large scale clinical centers, existing DoD consortia, and the scientific community." Dr. Stanhope said. "We have already begun promoting awareness of key orthopaedic research priorities and strengthening existing collaborative networks. Through the identification of strategic clinical pathways, we will fulfill one long-term goal of establishing a cadre of outcomes-oriented clinical research initiatives that result in the highest level of evidence-based orthopaedic rehabilitation care."

The consortium's acronym serves as a nod of respect to Sir Douglas Robert Steuart Bader, a member of Britain's Royal Air Force during World War II. Sir Bader lost two legs in a 1931 air show, yet ten years later, he served on active duty and participated in several aerial battles in the skies over Britain and France. He later became a champion and advocate of and for the disabled.


'/>"/>

Contact: Gail Whitehead
gail.whitehead@amedd.army.mil
301-619-7783
US Department of Defense Congressionally Directed Medical Research Programs
Source:Eurekalert

Related medicine news :

1. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
2. Akron Institute of Herzing University Launches Its First Bachelors Degree Programs to Prepare Students for Even Greater Success in Business, Health Care and IT
3. Most pandemic plans in Ontario hospitals have not been tested: Queens University study
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Smithsonian Institution, Arizona State University announce education and research partnership
6. Untreated poor vision in elderly linked to dementia, University of Michigan study shows
7. Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan
8. Arizona State Universitys Decision Theater offers balance to an off-kilter world
9. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
10. Herzing University Online Launches Master and Bachelor of Science Degrees in Nursing
11. Nurtur Acquires ActivHealth and Wellness by Choice; Gains Exclusive Partnership with Duke University Center for Living
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... An April 24th article on Yahoo! ... 180 pounds with the help of a weight loss surgery. The woman, declaring “I will ... that have been left following her dramatic weight loss. Dr. Feiz & Associates notes that, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Somnoware, a leading provider ... Online(TM), which enables sleep physicians to create and edit their interpretation reports. This ... provides a familiar interface that does not require additional training to use. It ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, ... the GlycoMark test throughout the Northeast U.S. , GlycoMark is the only ... The GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... ... cardiac or hERG liability could substantially improve drug safety and minimize the cost ... provided for validating ion channel inhibition using cell lines and for cardiac toxicity ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... The Mobile X-Ray product segment is the most attractive market ... period Mobile X-Ray segment is the largest segment ... market, which is estimated to be valued at more than ... 7% over the forecast period. Mobile X-Ray segment is expected ... Mn in 2017 over 2016. The segment,s revenue in the ...
(Date:4/19/2017)... 2017 Global Prostate Cancer Therapeutics Market: ... prostate cancer therapeutics market analyzes the current and ... of prostate cancer, launch of promising emerging therapies, ... new drugs & therapeutic biological products, and high ... lesser side effects are some of the drivers ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
Breaking Medicine Technology: